Henry Schein double upgraded to Buy from Underperform at BofA
BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...
Hold Rating on Henry Schein Amid KKR Investment and Market Uncertainties
In a report released on January 29, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein (HSIC – Research Report), ...
Henry Schein Inc. stock underperforms Tuesday when compared to competitors
This was the stock's fourth consecutive day of losses.
Newsday14d
Henry Schein gets $250 million investment from private equity firm KKR
Henry Schein and KKR said in its joint statement Wednesday the investment will give the company "expertise across finance, operations, and in dental and other areas of health care." The company ...
What Analysts Are Saying About Henry Schein Stock
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...
Morningstar8d
Velir Reimagines Henry Schein One's Digital Experience with Cutting-Edge Optimizely Implementation
This belief drove our collaboration with Henry Schein One, a division of Henry Schein, a leader in dental software solutions, to launch a dynamic new website designed to set the standard for ...
KKR builds stake in Henry Schein, reaches deal to add board seats
Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...
KKR Sinks Its Teeth Into Henry Schein With Additional Investment And Board Seats: Details
Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor ...